JPRN-jRCT2080220211未知2 期
A Phase 2/3, multicenter, randomized, investigator-blinded study to evaluate the efficacy and safety of NK-104 versus Atorvastatin in Chinese patients with hypercholesterolaemia
试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Main Inclusion Criteria:
- •Male or female patients diagnosed with hypercholesterolaemia
排除标准
- •Patients with homozygous familial hypercholesterolaemia
研究者
相似试验
进行中（未招募）
不适用
The purpose of the study is to compare and evaluate the generic Brinzolamide ophthalmic suspension with a registered and marketed Brinzolamide ophthalmic suspension as a treatment for ocular hypertension and glaucomaPatients suffering from open angle glaucoma and ocular hypertension with an elevated IOP, higher than 22mmHg and and lower or equal than 35 mmHgEUCTR2011-003692-12-PLAZAD Pharma AG90
进行中（未招募）
不适用
A clinical trial investigating safety and efficacy of a long-acting factor VIII in severe hemophila ASevere Hemophilia AMedDRA version: 14.1Level: LLTClassification code 10053753Term: Hemophilia A without inhibitorsSystem Organ Class: 100000004850EUCTR2011-005210-11-Outside-EU/EEABayer HealthCare AG140
进行中（未招募）
1 期
A clinical trial investigating safety and efficacy of a long-acting factor VIII in severe hemophila ASevere Hemophilia AMedDRA version: 20.0Level: LLTClassification code 10053753Term: Hemophilia A without inhibitorsSystem Organ Class: 100000011930EUCTR2011-005210-11-ATBayer AG145
进行中（未招募）
1 期
A clinical trial investigating safety and efficacy of a long-acting factor VIII in severe hemophila ASevere Hemophilia AMedDRA version: 15.0 Level: LLT Classification code 10053753 Term: Hemophilia A without inhibitors System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-005210-11-FRBayer HealthCare AG145
进行中（未招募）
1 期
A clinical trial investigating safety and efficacy of a long-acting factor VIII in severe hemophila AEUCTR2011-005210-11-BEBayer AG145